The Small Molecule Manufacturer
Our CCO, Christian Jones, shared his insights with The Medicine…
Nanoform establishes US subsidiary
Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
Our CCO, Christian Jones, talks to The Medicine Maker at CPhI Worldwide 2019
Our CCO, Christian Jones, joins The Medicine Maker to discuss…
Nanoform files for GMP certification
Nanoform has filed for GMP status with the Finnish Medicines Agency, FIMEA. The drug substance application for GMP clinical manufacture certification exemplifies its progress and growth in the last 12 months.
Chemistry World
Our CTO, Niklas Sandler, examines the importance of technological innovation…
Nanoform nominated for CPhI Award!
We are delighted to have been shortlisted as a finalist for the CPhI Award in the Excellence in Pharma: Formulation category.
Nanoform and AstraZeneca Initiate Technology Evaluation
Nanoform is delighted to announce the initiation of a technology evaluation of Nanoform’s Proprietary CESS Technology across a range of AstraZeneca’s proprietary pharmaceutical products.
Nanoform strengthens board with appointment of Mads Laustsen
Nanoform has appointed Mads Laustsen as a non-executive board member. This appointment will further strengthen the experienced Nanoform board and support the company as it increases its ability to deliver nanonized APIs for global partners across the pipeline from late stage drug discovery to commercial.